ロード中...
Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations
BACKGROUND: While surgery is the first-line treatment for patients with endogenous hypercortisolism (Cushing syndrome [CS]), mifepristone has been shown to be a beneficial medical treatment option, as demonstrated in the SEISMIC (Study of the Efficacy and Safety of Mifepristone in the Treatment of E...
保存先:
| 出版年: | Clin Diabetes Endocrinol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596972/ https://ncbi.nlm.nih.gov/pubmed/33292727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40842-020-00105-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|